Acurate Neo2 for valve-in-valve treatment of degenerated 3F Enable sutureless bioprosthetic valve in nonagenarian patient: a case report
ViV-TAVI is a well-established treatment for bioprosthetic valve failure in high-risk patients. However, sutureless valve degeneration presents a challenging scenario for ViV procedures, with only a limited number of cases performed using the Acurate platform. In this case, we demonstrated the technical feasibility of ViV using the Acurate system in a less explored surgical sutureless bioprosthesis.
Authors
- Andres Agustin Vecchia (ORCID: https://orcid.org/0000-0002-1295-3322)
- Giuseppe Migliaro
- Giuseppe Verolino (ORCID: https://orcid.org/0000-0002-2369-109X)
- Paolo Cioffi (ORCID: https://orcid.org/0000-0003-4732-4291)
- Dario Calderone (ORCID: https://orcid.org/0000-0002-9445-4294)
Institutions
- Università Campus Bio-Medico (IT)
- Azienda Sanitaria Locale Alessandria (IT)
- IRCCS Istituto Auxologico Italiano (IT)
Publication Details
- Journal
- European Heart Journal - Case Reports
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1093/ehjcr/ytaf073
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00